Science & Research
Cancer Patients Face Nutritional Challenges During Treatment as Companies Develop New Therapies
Cancer patients struggle with increased nutritional needs during treatment while facing eating difficulties, highlighting the importance of dietary management alongside medical advancements.
University of Pennsylvania Professor Barbara Riegel to Receive 2025 Clinical Research Prize for Self-Care Research
Barbara Riegel's pioneering work in self-care science for chronic illnesses like heart failure is being recognized with the American Heart Association's 2025 Clinical Research Prize, highlighting the growing importance of patient-centered care approaches in cardiovascular health.
Creative Biolabs Launches Advanced Neuroscience Platforms to Address Growing Neurodegenerative Disease Research Needs
Creative Biolabs has introduced specialized neuroscience research platforms targeting Alzheimer's and other neurodegenerative diseases, providing critical tools for studying cellular mechanisms in both peripheral and central nervous systems to accelerate drug development and mechanistic studies.
Adamera Minerals Expands High-Grade Gold Discovery at Glix Prospect in British Columbia
Adamera Minerals Corp. has identified significant gold anomalies at its Glix Prospect in British Columbia, with soil samples reaching 4.3 g/t gold, indicating potential for a major new discovery near historic mining operations.
Couple's 75-Year Marriage Highlights Health Benefits of Lifelong Partnerships
Tony and Marie Maltese's 75-year marriage demonstrates how strong relationships contribute to longevity and well-being, offering valuable insights into healthy aging.
Ocumetics Completes One-Month Postoperative Examinations for Revolutionary Intraocular Lens
Ocumetics Technology Corp. has completed critical one-month postoperative examinations for its innovative accommodating intraocular lens, marking a significant milestone in developing a potential vision correction solution that could eliminate the need for glasses or contact lenses.
Clene's CNM-Au8 Shows Promise in Addressing Cellular Dysfunction in Parkinson's Disease
Clene Inc.'s investigational therapy CNM-Au8 demonstrates potential to improve mitochondrial health and reduce inflammation in Parkinson's disease models, offering new hope for addressing the underlying cellular mechanisms driving neurodegeneration.
Oncotelic Therapeutics Featured in Editorial Highlighting Innovative Cancer and Rare Disease Pipeline
Oncotelic Therapeutics' inclusion in a NetworkNewsWire editorial underscores the company's growing prominence in developing RNA-based and immunotherapy treatments for aggressive cancers and pediatric rare diseases, positioning it for significant market growth.
Ares Strategic Mining Discovers Germanium in Utah Fluorspar Ore, Bolstering U.S. Critical Mineral Supply
Ares Strategic Mining's discovery of germanium alongside gallium in its Utah fluorspar ore enhances North American supply chain security for these critical minerals, reducing reliance on foreign sources.
Opawica Exploration Identifies Potential Multi-Million Ounce Gold System at Bazooka Property
Opawica Exploration's drilling results and geological analysis suggest the Bazooka Property could host a large, connected gold system along the prolific Cadillac-Larder Lake Fault, with significant implications for regional gold discovery potential.
Global Air Charters Secures NASA Airworthiness Recertification Through 2027
Global Air Charters has received NASA airworthiness recertification, ensuring continued support for critical space agency missions through May 2027 while meeting rigorous operational standards.
Blockchain Scholar Yu Xiong Elected Fellow of UK Academy of Social Sciences for Research Impact
Professor Yu Xiong's recognition for his influential work on cryptocurrency sustainability and Web3 innovation highlights the growing importance of academic research in shaping global digital policy and technological development.
Hong Kong and GBA Cities Forge Biomedical Partnership Driving Global Innovation Leadership
Hong Kong's biomedical sector has grown nearly 30% in the past decade, with collaborative efforts across the Greater Bay Area positioning the region as a global biotech innovation hub through financial resources, clinical trial capabilities, and cross-border partnerships.
NIH Grant Instability Disrupts Health Research and Minority Student Training Programs
The abrupt termination and subsequent reinstatement of National Institutes of Health grants has created significant disruptions to health research programs and minority student training initiatives, highlighting how funding uncertainty hampers scientific progress and diversity efforts.
GeoVax's Multi-Antigen COVID-19 Vaccine Shows Superior Immune Response in CLL Patients Compared to mRNA Vaccines
GeoVax's GEO-CM04S1 vaccine demonstrated significantly better immune response in chronic lymphocytic leukemia patients than standard mRNA vaccines, addressing a critical unmet need in immunocompromised populations.
American Heart Association Launches Major Initiative to Address Treatment Gaps in Common Heart Failure Types
The American Heart Association's new three-year IMPLEMENT-EF initiative aims to improve care for the 75% of heart failure patients with preserved or mildly reduced ejection fraction, addressing significant evidence gaps through multidisciplinary team approaches and real-world data analysis.
UCLA Researcher Peter Tontonoz to Receive 2025 American Heart Association Basic Research Prize for Lipid Metabolism Discoveries
Dr. Peter Tontonoz's groundbreaking research on cholesterol and lipid metabolism has transformed understanding of cardiovascular diseases and paved the way for new treatments beyond statins.
Hot and Cold Therapy Gains Scientific Backing for Heart Health and Immune Benefits
Medical expert Dr. Roger Seheult explains how combining sauna use with cold plunging provides significant cardiovascular and immune system benefits through ancient practices now supported by modern science.
Study Links Sucralose Consumption to Reduced Effectiveness of Cancer Immunotherapy
University of Pittsburgh research reveals that regular consumption of the artificial sweetener sucralose may diminish the effectiveness of immunotherapy treatments and reduce survival times in cancer patients.
Oncotelic Therapeutics Reports Two Years of Clinical Progress Across Oncology and Rare Disease Programs
Oncotelic Therapeutics has achieved significant clinical milestones over the past two years, advancing multiple late-stage programs including OT-101 for pancreatic cancer and OXi4503 for AML/MDS, positioning the company to address multi-billion-dollar markets with high unmet medical needs.
Gilat Introduces AI-Powered Network Management System for Satellite Communications
Gilat Satellite Networks has launched the industry's first AI-driven network management system that enables automated monitoring, anomaly detection, and dynamic resource allocation for satellite networks, representing a significant advancement in satellite communication technology.
GeoVax's Multi-Antigen COVID-19 Vaccine Shows Strong Immune Response in Immunocompromised Patients
GeoVax Labs' GEO-CM04S1 vaccine demonstrates robust immunity in high-risk patients with blood cancers, potentially addressing a multi-billion dollar market where current vaccines have limited effectiveness.
Neuroscience Breakthrough Offers New Hope for Locked-In Syndrome Patients and Consciousness Research
Dr. Berenika Maciejewicz's research provides a new diagnostic framework for detecting consciousness in locked-in syndrome patients, with significant implications for brain-computer interfaces and neurological care.
Spark Biomedical Secures Wellcome Leap Funding to Advance Women's Health Neurostimulation Technology
Spark Biomedical's recent funding from Wellcome Leap will enable FDA-style clinical trials for its OhmBody wearable neurostimulation device, which has shown promising results in reducing menstrual bleeding and symptoms, representing a significant advancement in addressing long-neglected women's health needs.
Cybin Executives to Present at TD Cowen Neuropsychiatry Summit Amid Phase 3 Depression Treatment Development
Cybin Inc. executives will present at the TD Cowen Neuropsychiatry & Epilepsy Summit, highlighting the company's late-stage development of novel mental health treatments including CYB003, which has received FDA Breakthrough Therapy Designation for major depressive disorder.
Kairos Pharma to Host Key Opinion Leader Event on Phase 2 Prostate Cancer Trial Results
Kairos Pharma will present interim efficacy results from its Phase 2 trial of ENV105 in advanced prostate cancer, potentially addressing critical drug resistance challenges in oncology treatment.
Sigyn Therapeutics Appoints Dr. Christoph Zaba to Scientific Advisory Board to Advance Dialysis-Like Cardiovascular Therapy
Sigyn Therapeutics has appointed Dr. Christoph Zaba, an expert in extracorporeal therapies, to its Scientific Advisory Board to support the development of Sigyn Therapy™, a novel treatment designed to reduce cardiovascular disease risk factors using existing dialysis infrastructure.
FORTA Opens World's First Dedicated Asphalt and Concrete Fiber Testing Laboratory
FORTA has established the world's first ISO 17025 certified laboratory dedicated to asphalt and concrete fiber testing, representing a significant advancement in infrastructure material validation and innovation.
Aston Bay Holdings Reports Promising Geophysical Results at Storm Copper Project
Aston Bay Holdings' final geophysical survey at the Storm Copper Project reveals significant conductive anomalies indicating potential high-grade copper sulphide mineralization, positioning the project to capitalize on growing copper demand from electrification and renewable energy sectors.
NanoViricides to Present Broad-Spectrum Antiviral Platform at LSX World Congress 2025
NanoViricides will showcase its clinical-stage nanoviricide technology targeting multiple viral diseases at the LSX World Congress, highlighting its potential to address unmet medical needs through a novel antiviral approach.